Suppr超能文献

选择性5-HT1D受体拮抗剂GR 127935对舒马曲坦所致猪颈动脉血管反应的阻断作用。

Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist.

作者信息

De Vries P, Heiligers J P, Villalón C M, Saxena P R

机构信息

Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands.

出版信息

Br J Pharmacol. 1996 May;118(1):85-92. doi: 10.1111/j.1476-5381.1996.tb15370.x.

Abstract
  1. It has previously been shown that the antimigraine drug, sumatriptan, a putative 5-HT1D receptor agonist, decreases porcine common carotid and arteriovenous anastomotic blood flows, but slightly increases the arteriolar (capillary) blood flow to the skin and ears. Interestingly, such responses, being mediated by 5-HT1-like receptors, are resistant to blockade by metergoline, which, in addition to displaying a very high affinity for (and occasionally intrinsic efficacy at) the 5-HT1D receptor subtypes, blocks (with lower potency than methiothepin) some 5-HT1D receptor-mediated vascular responses. These findings raise doubts whether sumatriptan-sensitive 5-HT1-like receptors mediating changes in the distribution of porcine carotid blood flow are identical to cloned 5-HT1D receptors. With the recent advent of the potent and selective 5-HT1D receptor antagonist, GR127935, we have examined in the present study whether the carotid vascular effects of sumatriptan in the pig are amenable to blockade by GR127935. 2. In animals pretreated with saline, sumatriptan (30, 100 and 300 micrograms kg-1, i.v.) reduced the total carotid and arteriovenous anastomotic blood flows in a dose dependent manner. In contrast, sumatriptan increased blood flow to the skin, ears and fat, although the total capillary fraction was not significantly affected. 3. While GR127935 pretreatment (0.25 and 0.5 mg kg-1) itself slightly reduced the total carotid and arteriovenous anastomotic blood flows, carotid vasoconstrictor responses to sumatriptan were either partly (0.25 mg kg-1) or completely (0.5 mg kg-1) blocked by the compound. In GR127935 pretreated animals, the sumatriptan-induced increases in blood flow to the skin, ears and fat were also attenuated. 4. Taken together, the results suggest that arteriovenous anastomotic constriction and, possibly, arteriolar dilatation in the skin, ears and fat by sumatriptan are mediated by 5-HT1D receptors. Therefore, vascular 5-HT1-like receptors in the porcine carotid bed appear to be identical to 5-HT1D receptors.
摘要
  1. 先前的研究表明,抗偏头痛药物舒马曲坦是一种假定的5-HT1D受体激动剂,可降低猪颈总动脉和动静脉吻合处的血流量,但会略微增加皮肤和耳朵的小动脉(毛细血管)血流量。有趣的是,这种由5-HT1样受体介导的反应对麦角林的阻断具有抗性,麦角林除了对5-HT1D受体亚型具有非常高的亲和力(偶尔还具有内在活性)外,还能阻断(效力低于甲硫噻嗪)一些5-HT1D受体介导的血管反应。这些发现使人怀疑,介导猪颈动脉血流分布变化的对舒马曲坦敏感的5-HT1样受体是否与克隆的5-HT1D受体相同。随着强效选择性5-HT1D受体拮抗剂GR127935的近期出现,我们在本研究中检测了舒马曲坦对猪颈动脉的血管作用是否可被GR127935阻断。2. 在生理盐水预处理的动物中,舒马曲坦(静脉注射,剂量为30、100和300微克/千克)以剂量依赖性方式降低了颈总动脉和动静脉吻合处的总血流量。相比之下,舒马曲坦增加了皮肤、耳朵和脂肪的血流量,尽管总毛细血管部分未受到显著影响。3. 虽然GR127935预处理(剂量为0.25和0.5毫克/千克)本身略微降低了颈总动脉和动静脉吻合处的总血流量,但该化合物可部分(0.25毫克/千克)或完全(0.5毫克/千克)阻断对舒马曲坦的颈动脉血管收缩反应。在GR127935预处理的动物中,舒马曲坦引起的皮肤、耳朵和脂肪血流量增加也有所减弱。4. 综上所述,结果表明舒马曲坦引起的动静脉吻合处收缩以及皮肤、耳朵和脂肪中可能的小动脉扩张是由5-HT1D受体介导的。因此,猪颈动脉床中的血管5-HT1样受体似乎与5-HT1D受体相同。

相似文献

引用本文的文献

5
Acute treatment of migraine and the role of triptans.偏头痛的急性治疗及曲坦类药物的作用
Curr Neurol Neurosci Rep. 2001 Mar;1(2):125-32. doi: 10.1007/s11910-001-0007-9.

本文引用的文献

3
Clinical and experimental effects of sumatriptan in humans.舒马曲坦对人体的临床及实验效果。
Trends Pharmacol Sci. 1993 Apr;14(4):129-33. doi: 10.1016/0165-6147(93)90084-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验